Journal of Chemistry

Journal of Chemistry / 2009 / Article

Open Access

Volume 6 |Article ID 190346 | 8 pages | https://doi.org/10.1155/2009/190346

Phytochemical Composition and Biological Activities of Uvaria chamae and Clerodendoron splendens

Received29 Jun 2008
Accepted01 Sep 2008

Abstract

Uvaria chamae P. Beauv and Clerodendron splendens A Cheval are known to have various medicinal and therapeutic properties. Their anti-inflammatory and oxytocic properties were assessed in this study. The extracts and aspirin were found to inhibit carrageenan-induced paw oedema on albino rats and mice with a strong activity in aspirin having (80.43 %) inhibition while U. chamae and C. splendens have 69.57% and 47.83% inhibition respectively. The plants extract exhibition and uterine contraction activity on guinea pig. Phytochemical studies on the plants revealed the presence of bioactive components comprising flavonoids (0.70 – 5.70 mg. 100 g-1), alkaloids (0.81-5.40 mg. 100 g-1), tannins (0.40 – 3.60 mg. 100 g-1), saponins (0.38 – 2.10 mg. 100 g-1) and phenols (0.08 – 0.10 mg. 100 g-1). These bioactive compounds may be responsible for the medicinal properties of U. chaemae and C. splendens that form the basis of their use in herbal medicine in Nigeria.

Copyright © 2009 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

808 Views | 4659 Downloads | 17 Citations
 PDF  Download Citation  Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.